United States · FDA National Drug Code directory
Ticagrelor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11788-157_99a77975-6abf-4109-9b18-7baf9ccb8836
- Product NDC
- 11788-157
- Form
- TABLET
- Composition / generic term
- Ticagrelor
- Labeler
- AiPing Pharmaceutical, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260610
- Source listing expiry
- 20271231
Source-listed ingredients
- TICAGRELOR — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (11788-157-60) · 11788-157-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →